GNLX
Price
$3.34
Change
-$0.13 (-3.75%)
Updated
Jul 25 closing price
Capitalization
126.12M
23 days until earnings call
PROK
Price
$3.29
Change
+$0.03 (+0.92%)
Updated
Jul 25 closing price
Capitalization
438.95M
11 days until earnings call
Interact to see
Advertisement

GNLX vs PROK

Header iconGNLX vs PROK Comparison
Open Charts GNLX vs PROKBanner chart's image
Genelux
Price$3.34
Change-$0.13 (-3.75%)
Volume$107.96K
Capitalization126.12M
ProKidney
Price$3.29
Change+$0.03 (+0.92%)
Volume$2.79M
Capitalization438.95M
GNLX vs PROK Comparison Chart in %
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. PROK commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (GNLX: $3.34 vs. PROK: $3.29)
Brand notoriety: GNLX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 78% vs. PROK: 16%
Market capitalization -- GNLX: $126.12M vs. PROK: $438.95M
GNLX [@Biotechnology] is valued at $126.12M. PROK’s [@Biotechnology] market capitalization is $438.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both GNLX and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • GNLX’s TA Score: 3 bullish, 5 bearish.
  • PROK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PROK is a better buy in the short-term than GNLX.

Price Growth

GNLX (@Biotechnology) experienced а +0.30% price change this week, while PROK (@Biotechnology) price change was +4.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

GNLX is expected to report earnings on Aug 19, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($439M) has a higher market cap than GNLX($126M). PROK YTD gains are higher at: 94.675 vs. GNLX (41.525). GNLX has higher annual earnings (EBITDA): -28.78M vs. PROK (-160.12M). PROK has more cash in the bank: 328M vs. GNLX (35.1M). GNLX has less debt than PROK: GNLX (1.79M) vs PROK (3.37M). PROK has higher revenues than GNLX: PROK (306K) vs GNLX (0).
GNLXPROKGNLX / PROK
Capitalization126M439M29%
EBITDA-28.78M-160.12M18%
Gain YTD41.52594.67544%
P/E RatioN/AN/A-
Revenue0306K-
Total Cash35.1M328M11%
Total Debt1.79M3.37M53%
TECHNICAL ANALYSIS
Technical Analysis
GNLXPROK
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 24 days ago
89%
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 9 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMFG49.00N/A
N/A
Decker Manufacturing Corp.
BLWYY30.43N/A
N/A
Bellway Plc.
LNNGY54.01-0.95
-1.73%
Li Ning Co., Ltd.
PIFYF0.54-0.02
-3.41%
Pine Cliff Energy Ltd.
PNPFF11.20-0.68
-5.72%
Pinetree Capital Ltd.

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with SYRE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-3.75%
SYRE - GNLX
34%
Loosely correlated
+1.08%
SNSE - GNLX
32%
Poorly correlated
-2.51%
LGVN - GNLX
32%
Poorly correlated
-1.18%
BEAM - GNLX
31%
Poorly correlated
+3.68%
PROK - GNLX
31%
Poorly correlated
+0.92%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with LGVN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then LGVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+0.92%
LGVN - PROK
42%
Loosely correlated
-1.18%
NRIX - PROK
39%
Loosely correlated
-0.09%
APGE - PROK
38%
Loosely correlated
-1.97%
CGEM - PROK
37%
Loosely correlated
-1.80%
KYMR - PROK
37%
Loosely correlated
-0.13%
More